[Canton Strategic Holdings Completes Sale of Gravitas, Transitions to Financial Digitalization Business] According to PRNewswire, Nasdaq-listed company Canton Strategic Holdings has completed the sale of its biotechnology R&D division, Gravitas Life Sciences, to Gravitas Collective Corp. The transaction was finalized on July 17, 2026. The company is transitioning to focus on the digitalization of financial markets and asset tokenization through the Canton Network.